tiprankstipranks
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market

Tenax Therapeutics (TENX) Income Statement

Compare
568 Followers

Tenax Therapeutics Income Statement

Last quarter (Q3 2024), Tenax Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Tenax Therapeutics's net income was $-3.96M. See Tenax Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -7.57K$ -113.33K$ -108.98K$ -114.75K
Operating Expenses
$ 19.49M$ 8.23M$ 11.05M$ 32.73M$ 9.87M
Depreciation and Amortization
$ 0.00$ 7.57K$ 113.33K$ 108.98K$ 114.75K
EBITDA
$ 0.00$ -8.23M$ -10.93M$ -32.36M$ -9.74M
Operating Income
$ 0.00-$ -11.05M$ -32.73M$ -9.87M
Other Income/Expenses
$ 0.00$ 523.27K$ 4.75K$ 253.88K$ 16.54K
Pretax Income
$ -17.60M$ -7.71M$ -11.05M$ -32.47M$ -9.85M
Net Income
$ -17.60M$ -7.71M$ -11.04M$ -32.73M$ -9.87M
Per Share Metrics
Basic EPS
$ -0.12$ -31.09$ -600.46$ -2.55K$ -1.52K
Diluted EPS
$ -0.12$ -31.04$ -600.46$ -2.55K$ -1.52K
Weighted Average Shares Outstanding
152.72M 248.00K 18.39K 12.86K 6.48K
Weighted Average Shares Outstanding (Diluted)
152.72M 248.45K 18.39K 12.86K 6.48K
Currency in USD

Tenax Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis